ARCHIVES

Adding Aresenic To Therapy Improves APL Survival

This article is from The Cancer Letter archive.

Vol. 30 No. 7 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

July 25, 2014

ORI Withdraws Requirement For Research Ethics Courses.

February 23, 2001

NIH Priority To Pay 4,000 Grants, Send Summary Statements

February 2, 1996

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009